Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A25012 IPKine™ HRP, Goat Anti-Mouse IgG LCS NTF4 plays a dual role in breast cancer in mammary tumorigenesis and metastatic progression(A25012-9) 9 Int J Biol Sci
KTA4002 Mitochondrial Permeability Transition Pore Assay N-terminal α-amino SUMOylation promotes phosphorylation-independent cofilin-1 translocation to the mitochondrial matrix and induces apoptosis(KTA4002-15.7) 15.7 International Journal of Biological Sciences 
KTD3001 Protein Quantification Kit (BCA Assay) NuanXin Formula inhibits bone resorption to combat osteoporosis by attenuating osteoclast oxidative phosphorylation(KTD3001-5.4) 5.4 Arthritis Research & Therapy 
A21020 HRP, Goat Anti-Rabbit IgG NTRK1-mediated protection against manganese-induced neurotoxicity and cell apoptosis via IGF2 in SH-SY5Y cells(A21020-7.5) 7.5 Molecular Medicine Reports
A21010 HRP, Goat Anti-Mouse IgG NuanXin Formula inhibits bone resorption to combat osteoporosis by attenuating osteoclast oxidative phosphorylation.(A21010-5.4) 5.4 Journal of Ethnopharmacology 
A21020 HRP, Goat Anti-Rabbit IgG NuanXin Formula inhibits bone resorption to combat osteoporosis by attenuating osteoclast oxidative phosphorylation.(A21020-5.4) 5.4 Journal of Ethnopharmacology
A25022 IPKine™ HRP, Mouse Anti-Rabbit IgG LCS NuanXin Formula inhibits bone resorption to combat osteoporosis by attenuating osteoclast oxidative phosphorylation.(A25022-5.4) 5.4 Journal of Ethnopharmacology
BMU102 NuanXin Formula inhibits bone resorption to combat osteoporosis by attenuating osteoclast oxidative phosphorylation.(BMU102-5.4) 5.4 Journal of Ethnopharmacology 
BMU111 Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2.(BMU111-15) 15 Bone Research 
KTI1020 Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2.(KTI1020-15) 15 Bone Research